STOCK TITAN

Exzeo Group (XZO) CEO buys 2,000 shares, now holds 1.62M

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Exzeo Group, Inc. Chief Executive Officer Paresh Patel reported an open-market purchase of 2,000 shares of common stock at $16.94 per share. Following this trade, he directly holds 1,618,013 common shares. He also holds a stock option granted on October 1, 2021 to buy 5,000,000 shares of common stock at an exercise price of $23.00 per share, vesting over time and expiring on October 1, 2031.

Positive

  • None.

Negative

  • None.
Insider Patel Paresh
Role Chief Executive Officer
Bought 2,000 shs ($34K)
Type Security Shares Price Value
Purchase Common Stock 2,000 $16.94 $34K
holding Stock Option (Right to Buy) -- -- --
Holdings After Transaction: Common Stock — 1,618,013 shares (Direct, null); Stock Option (Right to Buy) — 5,000,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Open-market purchase 2,000 shares at $16.94 Common Stock bought on April 17, 2026
Post-transaction holdings 1,618,013 shares Common Stock directly owned after purchase
Stock option size 5,000,000 underlying shares Option grant dated October 1, 2021
Option exercise price $23.00 per share Stock Option (Right to Buy) over common stock
Option expiration October 1, 2031 End date of CEO stock option
open-market purchase financial
"Purchase in open market or private transaction"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"exercise price of $23.00 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration date: 2031-10-01T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vested financial
"The option vested with respect to one fourth of the shares"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Patel Paresh

(Last)(First)(Middle)
1000 CENTURY PARK DRIVE

(Street)
TAMPA FLORIDA 33607

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Exzeo Group, Inc. [ XZO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/17/2026P2,000A$16.941,618,013D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$23 (1)10/01/2031Common Stock5,000,0005,000,000D
Explanation of Responses:
1. On October 1, 2021, the reporting person was granted an option to purchase 5,000,000 shares of common stock. The option vested with respect to one fourth of the shares on October 1, 2022 and with respect to one sixteenth of the shares on each January 1, April 1, July 1 and October 1 thereafter.
/s/ Brook A. Baker, Attorney-in-Fact for Paresh Patel04/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Exzeo Group (XZO) report for Paresh Patel?

Exzeo Group CEO Paresh Patel reported buying 2,000 shares of common stock in an open-market transaction at $16.94 per share. This Form 4 filing reflects a routine insider purchase, increasing his directly held stake in the company.

How many Exzeo Group (XZO) shares does CEO Paresh Patel own after this trade?

After the reported purchase, CEO Paresh Patel directly owns 1,618,013 shares of Exzeo Group common stock. This total includes his existing holdings plus the additional 2,000 shares bought at $16.94 per share in the disclosed open-market transaction.

At what price did Exzeo Group’s CEO buy the newly reported shares?

Paresh Patel purchased 2,000 Exzeo Group common shares at $16.94 per share in an open-market transaction. The Form 4 identifies this as a purchase in the open market or a private transaction, adding modestly to his existing direct holdings.

What stock options over Exzeo Group (XZO) shares does Paresh Patel hold?

Paresh Patel holds a stock option to buy 5,000,000 Exzeo Group common shares at a $23.00 exercise price. Granted October 1, 2021, it vested beginning October 1, 2022 and continues vesting quarterly, with an expiration date of October 1, 2031.

How does the reported 2,000-share purchase compare to Paresh Patel’s option position?

The 2,000-share purchase is small compared with Paresh Patel’s option over 5,000,000 underlying shares at a $23.00 exercise price. The option grant, vesting over time until October 1, 2031, represents a much larger potential exposure to Exzeo Group stock.